These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2412054)

  • 1. Serotonin and the flow properties of blood.
    Walker RT; Matrai A; Bogar L; Dormandy JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S35-7. PubMed ID: 2412054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and haemorrheology.
    Dormandy JA
    Int J Cardiol; 1987 Feb; 14(2):213-9. PubMed ID: 3818137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketanserin on peripheral blood flow, haemorheology, and platelet function in patients with Raynaud's phenomenon.
    Longstaff J; Gush R; Williams EH; Jayson MI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S99-101. PubMed ID: 2412071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs.
    De Clerck F; Jageneau A; Dom J
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):100-15. PubMed ID: 7138138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin and red blood cell sodium content in hypertension.
    De Cree J; Leempoels J; Demoen B; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S41-3. PubMed ID: 2412056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketanserin on platelet function and red cell filterability in hypertension and peripheral vascular disease.
    Zannad F; Voisin P; Pointel JP; Schmitt C; Freitag B; Stoltz JF
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S32-4. PubMed ID: 2412053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood rheology in vitro and in vivo.
    Lowe GD
    Baillieres Clin Haematol; 1987 Sep; 1(3):597-636. PubMed ID: 3327559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
    Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood rheology in general medicine and surgery.
    Lowe GD
    Baillieres Clin Haematol; 1987 Sep; 1(3):827-61. PubMed ID: 3327567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?
    Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S120-2. PubMed ID: 2412031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet hypersensitivity to serotonin after prolonged ketanserin intake?
    Arnout J; Van Russelt M; Deckmyn H; Vermylen J; Fiocchi R; Lijnen P; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S20-2. PubMed ID: 2412049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.
    Marasini B; Bassani C
    Br J Clin Pharmacol; 1990 Dec; 30(6):847-51. PubMed ID: 2288831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
    Lampugnani MG; de Gaetano G
    Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.
    De Clerck F; Xhonneux B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S23-5. PubMed ID: 2412050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.